Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma
Clinical trial NCT04397679 · TERMINATED
Trial details
- NCT number
- NCT04397679
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-12
- Primary completion
- 2024-05-14
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.